Navigation Links
New blood test may help in the fight against lung cancer
Date:5/3/2010

A new blood test could increase the success of a popular lung cancer drug called erlotinib by allowing doctors select which patients will react positively to the drug.

Currently, patients with non-small cell lung cancer receive erlotinib after chemotherapy and other drugs have failed. But erlotinib will only shrink the tumour about 10 per cent of the time.

"This is a step in the right direction that will allow us to eventually personalize a patient's treatment," says Queen's University Oncology professor Lesley Seymour, who was the coordinating physician on the study. "At the moment, we give drugs to patients and if they respond, we are happy and continue the treatment. If they don't, we move on to another drug."

In addition to helping doctors select the best drug treatment for patients, tests such as these will reduce exposure to medical side effects like rash and diarrhea caused by erlotinib, and eliminate financial burdens for a drug that may not benefit the patient. Newer drugs such as erlotinib can cost thousands of dollars for a month of treatment.

The current research is a follow-up to an erlotinib clinical trial between 2001 and 2005 at the Queen's University-based National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), which led to the approval of erlotinib in the treatment of non-small cell lung cancer.

In addition, blood and tissue samples collected in the original trials were used by David Carbone of the Vanderbilt-Ingram Cancer Center in Nashville to validate the blood tests. NCIC CTG and Queen's researchers also did the statistical analysis.

Professor Carbone presented his results on April 30 at the European Society for Medical Oncology Conference in Geneva, Switzerland.

Lung cancer is by far the deadliest form of cancer. There are 24,000 new cases of lung cancer diagnosed every year in Canada and 21,000 deaths.


'/>"/>

Contact: Michael Onesi
Michael.Onesi@queensu.ca
61-353-360-007-7513
Queen's University
Source:Eurekalert

Page: 1

Related medicine news :

1. Despite tests, high blood pressure hard to recognize in children
2. Blood test may identify lung cancer patients likely to respond to erlotinib
3. Watch Your Cholesterol, Your Blood Pressure ... and This Enzyme?
4. Tight Blood Sugar Control May Not Harm Diabetics
5. Study examines global availability of treatment involving transplantation of blood stem cells
6. Low blood oxygen may lead to heart defects in children with sickle cell disease
7. InBoundMarketingPR: Cord Blood America Newest Inbound Marketing Client
8. USPack Courier Brings Tracking Precision to Medical and Blood Shipments
9. MDS, a blood cancer, strikes nearly 5 times more Americans than previously thought
10. JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April)
11. Knowledge is power in Penn State blood pressure study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Shamangelic Healing, Sedona Arizona's Premier ... Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and wellness to ... the store is just one more way Shamangelic Healing supports people’s quest for ...
(Date:4/29/2016)... ... 29, 2016 , ... The White House announced efforts yesterday ... information about their loan terms and accounts, and more protections for borrowers. The ... and private loans, has reached $1.3 trillion, with 43 million Americans holding student ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton School of ... Grand Prize of the 2016 Wharton Business Plan Competition —as well as ... Award, and the Committee Award for Most ‘Wow Factor,’ making them the first ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... Cosmetic dentistry is a fast-growing field as more patients are discovering the many different ... more about the options currently available to them and which ones might work for ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology ... appointment of Dr. Alfredo Zurlo as Chief ... with many years clinical experience and a proven track ... role was at Mologen AG where he was Chief ... Dr. Zurlo held various positions at F Hoffmann La ...
(Date:4/28/2016)... Research and Markets has announced the addition ... report to their offering.      (Logo: ... plastic surgery products market is expected to grow at ... ,The growing adoption of laser in aesthetics is another ... Lasers are used to treat a broad range of ...
(Date:4/28/2016)... April 28, 2016 Treato ... on healthcare, announced today that it has been named ... Cool Vendor in Life Sciences, 2016, Stephen ...  The report focuses on life-science- oriented analytics, algorithms and ... patients and doctors, confirm medication ingestion, and analyze unstructured ...
Breaking Medicine Technology: